KAYLA STOICK: Open Payments
NPI 1427539626 · ENGLEWOOD, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$10,740 in 187 payments from 27 companies in 2025. Trend: 2023 $3,775 · 2024 $4,659 · 2025 $10,740
Food & beverage: $6,630Consulting: $2,930Travel & lodging: $789Speaker / faculty: $340Education: $51
| Company | Payments | Amount |
|---|---|---|
| Genentech USA, Inc. | 5 | $2,663 |
| Janssen Biotech, Inc. | 17 | $2,398 |
| ABBVIE INC. | 29 | $909 |
| Ardelyx, Inc. | 11 | $773 |
| Ipsen Biopharmaceuticals, Inc | 12 | $568 |
| GENZYME CORPORATION | 11 | $497 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 18 | $454 |
| Takeda Pharmaceuticals U.S.A., Inc. | 14 | $440 |
| Lilly USA, LLC | 12 | $263 |
| Regeneron Healthcare Solutions, Inc. | 8 | $217 |
Products named: TREMFYA, IBSRELA, DUPIXENT, IQIRVO, XIFAXAN, ENTYVIO, RINVOQ, SKYRIZI.
Industry payments across CO — which companies pay providers there.
